169 related articles for article (PubMed ID: 27894518)
1. Radiation maculopathy treated with intravitreal bevacizumab.
Sánchez-Vicente JL; Muñoz-Morales A; Galván-Carrasco MP; Castilla-Lázpita A; Vital-Berral C; Alfaro-Juárez A; Rueda-Rueda T
Arch Soc Esp Oftalmol; 2017 Jun; 92(6):283-286. PubMed ID: 27894518
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
Mason JO; Albert MA; Persaud TO; Vail RS
Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
Finger PT; Chin KJ; Semenova EA
Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
[TBL] [Abstract][Full Text] [Related]
6. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
7. DEXAMETHASONE INTRAVITREAL IMPLANT VS RANIBIZUMAB IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRACHYTHERAPY FOR CHOROIDAL MELANOMA.
Russo A; Reibaldi M; Avitabile T; Uva MG; Franco LM; Gagliano C; Bonfiglio V; Spatola C; Privitera G; Longo A
Retina; 2018 Apr; 38(4):788-794. PubMed ID: 28272283
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma.
Fallico M; Reibaldi M; Avitabile T; Longo A; Bonfiglio V; Chronopoulos A; Caltabiano R; Spatola C; Russo A
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1547-1554. PubMed ID: 31081526
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
Ziemssen F; Voelker M; Altpeter E; Bartz-Schmidt KU; Gelisken F
Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
[No Abstract] [Full Text] [Related]
10. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
[TBL] [Abstract][Full Text] [Related]
11. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
12. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.
Finger PT; Chin K
Arch Ophthalmol; 2007 Jun; 125(6):751-6. PubMed ID: 17562985
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal dexamethasone implant in radiation-induced macular oedema.
Frizziero L; Parrozzani R; Trainiti S; Pilotto E; Miglionico G; Pulze S; Midena E
Br J Ophthalmol; 2017 Dec; 101(12):1699-1703. PubMed ID: 28404670
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
Daruich A; Matet A; Schalenbourg A; Zografos L
Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
[TBL] [Abstract][Full Text] [Related]
15. Intravitreous ranibizumab (lucentis) for radiation maculopathy.
Finger PT; Chin KJ
Arch Ophthalmol; 2010 Feb; 128(2):249-52. PubMed ID: 20142553
[No Abstract] [Full Text] [Related]
16. Regression of radiation-induced macular edema after systemic bevacizumab.
Solano JM; Bakri SJ; Pulido JS
Can J Ophthalmol; 2007 Oct; 42(5):748-9. PubMed ID: 17823640
[TBL] [Abstract][Full Text] [Related]
17. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
[TBL] [Abstract][Full Text] [Related]
18. An atypical case of post surgery macular edema -Case report.
Triantafyllidis G; Filip M; Moisescu R; Filip A; Dragne C; Nicolae M
Rom J Ophthalmol; 2016; 60(3):195-199. PubMed ID: 29450348
[TBL] [Abstract][Full Text] [Related]
19. PARAFOVEAL CAPILLARY DENSITY AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA: Analysis of Eyes Without Radiation Maculopathy.
Say EA; Samara WA; Khoo CT; Magrath GN; Sharma P; Ferenczy S; Shields CL
Retina; 2016 Sep; 36(9):1670-8. PubMed ID: 27232466
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.
Shields CL; Demirci H; Dai V; Marr BP; Mashayekhi A; Materin MA; Manquez ME; Shields JA
Retina; 2005; 25(7):868-74. PubMed ID: 16205566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
